Sistigu, Antonella
 Distribuzione geografica
Continente #
NA - Nord America 775
EU - Europa 531
AS - Asia 157
SA - Sud America 2
Totale 1.465
Nazione #
US - Stati Uniti d'America 773
PL - Polonia 317
SE - Svezia 62
CN - Cina 55
IT - Italia 52
SG - Singapore 52
IE - Irlanda 31
ID - Indonesia 20
GB - Regno Unito 15
DE - Germania 13
VN - Vietnam 12
FR - Francia 9
RU - Federazione Russa 7
TR - Turchia 6
AT - Austria 5
BE - Belgio 5
UA - Ucraina 5
IN - India 4
HK - Hong Kong 3
IR - Iran 3
CH - Svizzera 2
CZ - Repubblica Ceca 2
IL - Israele 2
MX - Messico 2
NL - Olanda 2
BR - Brasile 1
CO - Colombia 1
ES - Italia 1
FI - Finlandia 1
NO - Norvegia 1
RO - Romania 1
Totale 1.465
Città #
Warsaw 316
Fairfield 118
Ashburn 93
Chandler 78
Woodbridge 63
Seattle 54
Cambridge 50
Redmond 47
Houston 40
Singapore 39
Wilmington 35
Dublin 31
Jakarta 18
Milan 14
Ann Arbor 13
Dong Ket 12
Rome 12
Dearborn 10
Los Angeles 9
Princeton 9
London 7
Boston 6
Izmir 6
Jacksonville 6
New York 6
Brussels 5
Moscow 5
Nanchang 5
Nanjing 5
San Mateo 5
Vienna 5
Beijing 4
Hangzhou 4
Phoenix 4
Washington 4
Kunming 3
Marseille 3
Norwalk 3
Acton 2
Brno 2
Chicago 2
Florence 2
Gorgonzola 2
Herzliya 2
Hong Kong 2
Jiaxing 2
Kilburn 2
Mexico City 2
Pittsburgh 2
San Diego 2
Zurich 2
Absecon 1
Andover 1
Augusta 1
Berlin 1
Boardman 1
Bogotá 1
Cattolica 1
Changchun 1
Chiswick 1
Chongqing 1
Fabriano 1
Fremont 1
Groningen 1
Gunzenhausen 1
Hebei 1
Helsinki 1
Iasi 1
Kish 1
Las Vegas 1
Mountain View 1
Ningbo 1
Novokuznetsk 1
Nuremberg 1
Oslo 1
Pescara 1
Salò 1
Shenyang 1
Surabaya 1
São Paulo 1
Wandsworth 1
Wuhan 1
Totale 1.204
Nome #
CHK1-targeted therapy to deplete DNA replication- stressed, p53-deficient, hyperdiploid colorectal cancer stem cells 359
Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018 254
Type-I-interferons in infection and cancer: Unanticipated dynamics with therapeutic implications 239
Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018 186
The targeting of mre11 or rad51 sensitizes colorectal cancer stem cells to chk1 inhibition 83
Control of replication stress and mitosis in colorectal cancer stem cells through the interplay of PARP1, MRE11 and RAD51 71
Type I interferons in infection and cancer: Unanticipated dynamics with therapeutic implications 47
Replication stress response in cancer stem cells as a target for chemotherapy 43
Tuning Cancer Fate: Tumor Microenvironment's Role in Cancer Stem Cell Quiescence and Reawakening 37
Type I IFNs promote cancer cell stemness by triggering the epigenetic regulator KDM1B 36
Mutational and Antigenic Landscape in Tumor Progression and Cancer Immunotherapy 27
The Yin and Yang of Type I IFNs in Cancer Promotion and Immune Activation 24
The Immune Privilege of Cancer Stem Cells: A Key to Understanding Tumor Immune Escape and Therapy Failure 21
Tumor-Intrinsic or Drug-Induced Immunogenicity Dictates the Therapeutic Success of the PD1/PDL Axis Blockade 16
Microfluidic Co-Culture Models for Dissecting the Immune Response in in vitro Tumor Microenvironments 16
Talniflumate abrogates mucin immune suppressive barrier improving efficacy of gemcitabine and nab-paclitaxel treatment in pancreatic cancer 13
Consensus guidelines for the definition, detection and interpretation of immunogenic cell death 13
Totale 1.485
Categoria #
all - tutte 6.212
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.212


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020196 0 0 0 0 21 34 37 19 29 14 33 9
2020/2021258 13 17 10 11 23 44 88 1 14 10 14 13
2021/2022109 14 8 4 5 5 10 4 12 8 6 17 16
2022/2023208 26 32 17 15 13 29 4 25 28 12 6 1
2023/2024199 4 51 9 30 17 14 14 2 4 9 25 20
2024/202584 10 11 41 6 16 0 0 0 0 0 0 0
Totale 1.485